<SEC-DOCUMENT>0001104659-25-011231.txt : 20250211
<SEC-HEADER>0001104659-25-011231.hdr.sgml : 20250211
<ACCEPTANCE-DATETIME>20250211085512
ACCESSION NUMBER:		0001104659-25-011231
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20250211
DATE AS OF CHANGE:		20250211

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			APPLIED DNA SCIENCES INC
		CENTRAL INDEX KEY:			0000744452
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-TESTING LABORATORIES [8734]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				592262718
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36745
		FILM NUMBER:		25607837

	BUSINESS ADDRESS:	
		STREET 1:		50 HEALTH SCIENCES DRIVE
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790
		BUSINESS PHONE:		631-240-8800

	MAIL ADDRESS:	
		STREET 1:		50 HEALTH SCIENCES DRIVE
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PROHEALTH MEDICAL TECHNOLOGIES INC
		DATE OF NAME CHANGE:	20010504

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DCC ACQUISITION CORP
		DATE OF NAME CHANGE:	19990211

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DATALINK CAPITAL CORP/TX/
		DATE OF NAME CHANGE:	19980306
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>tm256134d1_defa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 133.05pt 0pt 132.35pt; text-align: center">UNITED STATES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 133.05pt 0pt 132.35pt; text-align: center"><B>SECURITIES AND EXCHANGE
COMMISSION</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 131.2pt 0pt 132.35pt; text-align: center">Washington, D.C. 20549</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; color: Red"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; color: Red"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 131.15pt 0pt 132.35pt; text-align: center">SCHEDULE 14A</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 169.15pt 0pt 168.25pt; text-align: center">Proxy Statement Pursuant
to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;)</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; color: Red"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; color: Red">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Filed by the Registrant <FONT STYLE="font-family: Wingdings">&#120;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Filed by a Party other than
the Registrant <FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Check the appropriate box:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 5pt; width: 17.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD><TD STYLE="padding-bottom: 5pt">Preliminary Proxy Statement</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 5pt; width: 17.3pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="padding-bottom: 5pt"><B>Confidential, for Use of
                                            the Commission Only (as permitted by Rule 14a-6(e)(2))</B></TD></TR><TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="padding-bottom: 5pt">Definitive Proxy Statement</TD></TR>

<TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Wingdings">&#120;</FONT>&nbsp;</TD><TD STYLE="padding-bottom: 5pt">Definitive Additional Materials</TD></TR>
                                                                                                                                          <TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 5pt; width: 17.3pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="padding-bottom: 5pt">Soliciting Material
                                            Pursuant to &sect;240.14a-12</TD></TR></TABLE>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="border-bottom: Black 1pt solid; font-size: 14pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>Applied DNA Sciences, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 131.5pt 0pt 132.35pt; text-align: center">(Name of Registrant as Specified
In Its Charter)</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="border-bottom: Black 1pt solid; text-align: center; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; color: Red">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 131.5pt 0pt 132.35pt; text-align: center">(Name of Person(s) Filing Proxy
Statement, if other than the Registrant)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Payment of Filing Fee (Check all boxes that apply):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Wingdings">&#120;</FONT></TD><TD STYLE="padding-bottom: 5pt">No fee required.</TD></TR>
                                                                                                                                          <TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 5pt; width: 17.3pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="padding-bottom: 5pt">Fee paid previously with preliminary materials.</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="padding-bottom: 5pt">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>On February 11, 2025, Applied DNA Sciences, Inc. (the &#8220;Company&#8221;)
issued the following press release, which contains information relating to the Company&#8217;s 2025 Special Meeting of Stockholders, to
be held on February 14, 2025.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm256134d1_defa14aimg001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>Applied DNA Reminds Shareholders
to Vote Ahead of Special Meeting on February 14 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: #0A0A0A"><B>STONY BROOK,
N.Y. </B>&ndash; <B>February 11, 2025</B> - </FONT><U>Applied DNA Sciences, Inc.</U> <FONT STYLE="color: #0A0A0A">(NASDAQ: APDN) (&ldquo;Applied
DNA&rdquo; or the &ldquo;Company&rdquo;), a leader in PCR-based DNA technologies, today issued a reminder to its shareholders to vote
ahead of a reconvening of a Special Meeting of Stockholders (the &ldquo;Special Meeting&rdquo;) to be held on Friday, February 14, 2025
at 11:00 a.m. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: #0A0A0A">The
Company&rsquo;s Board of Directors encourages any shareholder as of the record date of November 25, 2024, who has not yet voted
their shares on the Warrant Exercise Proposal (as defined below), to contact Kingsdale Advisors to vote their shares:
1-855-682-9644&nbsp;or by e-mail at </FONT><U>contactus@kingsdaleadvisors.com</U><FONT STYLE="color: #0A0A0A">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: #0A0A0A">The Special Meeting
was originally held on January 23, 2025, but, due to a lack of quorum, was adjourned to allow additional time for the Company&rsquo;s
stockholders to vote on Proposal One (the &ldquo;Warrant Exercise Proposal&rdquo;) set forth in the Company&rsquo;s definitive proxy
statement (the &ldquo;Proxy Statement&rdquo;) filed with the U.S. Securities and Exchange Commission on </FONT><U>December 10, 2024</U><FONT STYLE="color: #0A0A0A">:
<I>to approve, in accordance with Nasdaq Listing Rule&nbsp;5635(d), the exercisability of certain common stock purchase warrants, and
the issuance of the common stock underlying such warrants, which warrants were issued in connection with an offering of securities of
the Company that occurred on October 30, 2024.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Applied DNA Sciences </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Applied DNA Sciences is a biotechnology company
developing technologies to produce and detect deoxyribonucleic acid (&ldquo;DNA&rdquo;). Using the polymerase chain reaction (&ldquo;PCR&rdquo;)
to enable both the production and detection of DNA, we currently operate in three primary business markets: (i) the enzymatic manufacture
of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNA polymerase
(&ldquo;RNAP&rdquo;) for use in the production of mRNA therapeutics; (ii) the detection of DNA and RNA in molecular diagnostics and genetic
testing services; and (iii) the manufacture and detection of DNA for industrial supply chain security services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Visit <U>adnas.com</U> for more information. Follow us on <U>X</U>
and <U>LinkedIn</U>. Join our <U>mailing list</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border: black 1pt solid; padding-right: 2pt; padding-left: 8pt; width: 100%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>YOUR VOTE IS IMPORTANT!</B>&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Your vote is important, and we ask that you please vote&nbsp;<B>&ldquo;FOR&rdquo;</B>&nbsp;the
    Warrant Exercise Proposal.&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For specific instructions on how to vote your shares, please refer
    to the instructions on the Notice of Internet Availability of Proxy Materials you received in the mail, the section entitled &ldquo;About
    the Special Meeting&rdquo; beginning on page&nbsp;1 of the Proxy Statement or, if you request to receive printed proxy materials, your
    enclosed proxy card.&nbsp;Please note that shares held beneficially in street name may be voted by you in person at the Special Meeting
    only if you obtain a legal proxy from the broker, bank, trustee, or other nominee that holds your shares giving you the right to vote
    the shares.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>If you have any questions or require any assistance with voting
    your shares, please call the Company&rsquo;s proxy solicitor, Kingsdale Advisors, at:</B>&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>1- 855-682-9644 (toll free) or 1-646-491-9095 (call or text outside
    North America) or by email at&nbsp;contactus@kingsdaleadvisors.com</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Additional Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with the Company&rsquo;s Special Meeting, the Company
has filed with the U.S. Securities and Exchange Commission (&ldquo;SEC&rdquo;) and mailed to the shareholders of record entitled to vote
at the Special Meeting a definitive proxy statement and other documents, including a proxy card. SHAREHOLDERS ARE ENCOURAGED TO READ THE
DEFINITIVE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) FILED BY THE COMPANY AND ALL OTHER RELEVANT DOCUMENTS WHEN
FILED WITH THE SEC AND WHEN THEY BECOME AVAILABLE BECAUSE THOSE DOCUMENTS WILL CONTAIN IMPORTANT INFORMATION. A copy of our Annual Report
on Form&nbsp;10-K for the fiscal year ended September&nbsp;30, 2024, including financial statements and any financial statement schedules
required to be filed in accordance with SEC rules, will be sent without charge to any stockholder of the Company requesting it in writing
from: Applied DNA Sciences,&nbsp;Inc., 50 Health Sciences Drive, Stony Brook, New York 11790, Attention: Beth Jantzen. We also make available,
free of charge on our website, all of our filings that are publicly filed on the SEC&rsquo;s EDGAR website, including Forms 10-K, 10-Q
and 8-K, at&nbsp;<I>www.adnas.com</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Relations contact: </B>Sanjay M. Hurry, 917-733-5573,
sanjay.hurry@adnas.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Web:</B> https://investors.adnas.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>X: </B>@APDN</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">###</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tm256134d1_defa14aimg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm256134d1_defa14aimg001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  X T,# 2(  A$! Q$!_\0
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M6VGZK?Z-#J5M*$NK*+7M#GF14U&#/IGQJ^+.C_!CP++XTU72?$'B.1]:\/\
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M1XU\+_LT:9_9'[+?[2?Q#TW4-.\6:KI_Q-UV\\'Z;IVI1:M<:LUSKOPQAO\
M2?%5DLFI:VEG+J4&C7U_+!I]KYGA'[0G[,GQW_X)>_LR_L@_\%*_ '[7?QD\
M<?%OXA^-/A%+\7?!WBG7=2OO!_B:Q^(_@?6/B3>^')DO]7U*YU:QCAT*^\,:
MG/JANI+UM1BU[3ET>YLD@F /[GY9X8(VEGFBAB3!>261(XT!Z%G<A5SD8R1F
MHTO;.2 W4=W;/:@,3<I/$T "DJQ,RN8P%8$-\W!!!Y%?RU_MC6?QX_X*2?\
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M\=_"]/$L6D:/XAN/#%]%XI\-:OX8O$U.VT^PU)C!!K%K:O=VS6NI6Q%S;>;
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M]I/XR_%#X2>+?%W[(G@;XB:3^T3K-A?:_I^I^/\ Q=XT\-:CI$>K?#G1]/\
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M1VUE8106\2 ,?E2-1DD]2372T44 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
E10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
